FEATURED NEWS

• HDA Statement in Opposition of New York State Opioid Tax

  March 30, 2018

  HDA President and CEO John M. Gray released the following statement after the passage of the 2019 New York State budget.

• Three Takeaways from the FDA Public Meetings on DSCSA

  March 26, 2018

  On February 28, FDA hosted its third and final public meeting in a series focused on "Enhanced Drug Distribution Security Under the Drug Supply Chain Security Act [DSCSA],” bringing together a broad group of stakeholders, including manufacturers, distributors, dispensers, hospitals and service providers.

• Building on Role as a Convener, HDA Launches Allied Against Opioid Abuse

  March 14, 2018

  As the logistics experts of healthcare, pharmaceutical distributors play a critical role in the day-to-day operations of the supply chain, but also when health challenges arise, such as a natural disaster or shortages in medicines.

• HDA Recognizes Dianne Pfahl of Cardinal Health with Distribution Management Award for Industry Leadership

  March 6, 2018

  The Healthcare Distribution Alliance (HDA) has honored Dianne Pfahl, Vice President, Strategic Sourcing National Brands, Cardinal Health, Inc., with the 2018 Distribution Management Award (DMA) for Industry Leadership. The award was presented at HDA’s Distribution Management Conference and Expo in Austin, Texas.

• Smith Drug Company Receives Distribution Management Award for Implementation of Cloud-Based Predictive Inventory Management System

  March 6, 2018

  Smith Drug Company, Div. J M Smith Corporation, has received the Healthcare Distribution Alliance’s (HDA) 2018 Distribution Management Award (DMA) for their implementation of a cloud-based predictive inventory management system (IMS). The award was presented at HDA’s Distribution Management Conference and Expo in Austin, Texas.